Literature DB >> 33456166

Dipeptidyl-peptidase-like protein 6 encephalitis treated with immunotherapy.

Lan Ye1, Margret Schnegelsberg1, Mark Obermann1.   

Abstract

This case describes a middle-aged man with anti-dipeptidyl-peptidase-like protein 6 (DPPX) encephalitis who exhibited the triad of memory loss, diarrhea, and tremor. The progression of his disease resembled neurodegenerative disease, and his first presentation at our department was 2 years after the first onset of symptoms. Antibodies against DPPX were positive in both serum and cerebrospinal fluid. No related tumor was found. The patient was initially treated with corticosteroid therapy and plasmapheresis. Despite moderate response to this treatment, corticosteroids were ceased because of adverse effects such as Cushing syndrome, deep vein thrombosis, and osteoporosis. After five cycles of treatment with rituximab, the patient experienced no further progression of neurologic symptoms and no adverse effects. The case adds to the understanding of the diagnosis, treatment, and potential prognosis of anti-DPPX encephalitis.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Anti-DPPX antibody; autoimmune encephalitis; corticosteroid therapy; rituximab

Year:  2020        PMID: 33456166      PMCID: PMC7785152          DOI: 10.1080/08998280.2020.1822132

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  12 in total

1.  The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels.

Authors:  Marcela S Nadal; Andrés Ozaita; Yimy Amarillo; Eleazar Vega-Saenz de Miera; Yuliang Ma; Wenjun Mo; Ethan M Goldberg; Yoshio Misumi; Yukio Ikehara; Thomas A Neubert; Bernardo Rudy
Journal:  Neuron       Date:  2003-02-06       Impact factor: 17.173

2.  [Progressive encephalitis due to anti-DPPX antibodies: a case with good response to treatment with rituximab].

Authors:  G Valero-Lopez; J J Martin-Fernandez; R Hernandez-Clares; A E Baidez-Guerrero; E Martinez-Hernandez
Journal:  Rev Neurol       Date:  2017-12-01       Impact factor: 0.870

3.  Antibody-associated CNS syndromes without signs of inflammation in the elderly.

Authors:  Domingo Escudero; Mar Guasp; Helena Ariño; Carles Gaig; Eugenia Martínez-Hernández; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2017-09-06       Impact factor: 9.910

4.  Anti-dipeptidyl-peptidase-like protein 6 encephalitis, a rare cause of reversible rapid progressive dementia and insomnia.

Authors:  Qinming Zhou; Xiaodong Zhu; Huanyu Meng; Min Zhang; Sheng Chen
Journal:  J Neuroimmunol       Date:  2019-11-18       Impact factor: 3.478

5.  Rituximab for Treatment of Refractory Anti-NMDA Receptor Encephalitis in a Pediatric Patient.

Authors:  Sarah Hallowell; Esli Tebedge; Margaret Oates; Elizabeth Hand
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Mar-Apr

6.  DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

Authors:  Makoto Hara; Helena Ariño; Mar Petit-Pedrol; Lidia Sabater; Maarten J Titulaer; Eugenia Martinez-Hernandez; Marco W J Schreurs; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2017-03-03       Impact factor: 9.910

7.  DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Authors:  William Oliver Tobin; Vanda A Lennon; Lars Komorowski; Christian Probst; Stacey Lynn Clardy; Allen J Aksamit; Juan Pablo Appendino; Claudia F Lucchinetti; Joseph Y Matsumoto; Sean J Pittock; Paola Sandroni; Maja Tippmann-Peikert; Elaine C Wirrell; Andrew McKeon
Journal:  Neurology       Date:  2014-10-15       Impact factor: 9.910

8.  [Autoimmune encephalitis due to mantle cell lymphoma].

Authors:  A A H Bressers; N A Goto; S Piepers; J C Regelink
Journal:  Ned Tijdschr Geneeskd       Date:  2016

9.  Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Authors:  Anna Boronat; Jeffrey M Gelfand; Nuria Gresa-Arribas; Hyo-Young Jeong; Michael Walsh; Kirk Roberts; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Bernardo Rudy; Josep Dalmau
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 10.  Treatment strategies for autoimmune encephalitis.

Authors:  Yong-Won Shin; Soon-Tae Lee; Kyung-Il Park; Keun-Hwa Jung; Ki-Young Jung; Sang Kun Lee; Kon Chu
Journal:  Ther Adv Neurol Disord       Date:  2017-08-16       Impact factor: 6.570

View more
  2 in total

1.  Anti-dipeptidyl-peptidase-like protein 6 encephalitis with pure cerebellar ataxia: a case report.

Authors:  Jing Lin; Min Zhu; Xiaocheng Mao; Zeqing Jin; Meihong Zhou; Daojun Hong
Journal:  BMC Neurol       Date:  2022-07-01       Impact factor: 2.903

Review 2.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.